Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04120610 · ClinicalTrials.gov registry record
FlowMet-R Blood Flow Measurement for the Diagnosis of Peripheral Artery Disease and Critical Limb Ischemia
A clinical trial, sponsored by Medtronic Endovascular.
- Terminated
- Registry status
- 195
- Enrollment target
NCT04120610 is a clinical trial that was terminated before completion, run by Medtronic Endovascular. The registered enrollment target is 195 participants.
The verdict
NCT04120610 was terminated before completion, sponsored by Medtronic Endovascular.
- TERMINATED
- Registry status
- 195 participants
- Enrollment target
Study Summary
Non-randomized, multi-center, longitudinal study of healthy subjects and subjects with PAD who are scheduled for ABI, TBI, and either Duplex Ultrasound or Angiographic assessments in a vascular clinic.
Interventions
- DIAGNOSTIC_TEST FlowMet-R
- DIAGNOSTIC_TEST ABI
- DIAGNOSTIC_TEST TBI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 195 participants |
| Start Date | 2019-12-09 |
| Est. Completion | 2022-11-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04120610
The ClinicalTrials.gov registry entry for NCT04120610 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 195 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Endovascular, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which FlowMet-R is the first listed.
NCT04120610 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04120610 about?
NCT04120610 is a clinical study titled "FlowMet-R Blood Flow Measurement for the Diagnosis of Peripheral Artery Disease and Critical Limb Ischemia". Non-randomized, multi-center, longitudinal study of healthy subjects and subjects with PAD who are scheduled for ABI, TBI, and either Duplex Ultrasound or Angiographic assessments in a vascular clinic.
What is the current status of trial NCT04120610?
This trial is currently terminated. The enrollment target is 195 participants. The study started on 2019-12-09. Estimated completion is 2022-11-21.
What interventions are being tested in trial NCT04120610?
The interventions under investigation include: FlowMet-R (DIAGNOSTIC_TEST), ABI (DIAGNOSTIC_TEST), TBI (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04120610?
This trial is sponsored by Medtronic Endovascular, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.